Back to Guavy Wire

Stocks

Merck & Co Inc Stock Down on Weak Performance

Guavy AI Editorial Team Published August 4, 2026

Instruments

MRK

Merck & Co Inc's stock price is currently trading at $128.27, down 1.48% from its previous close of $129.75.

The company has a market capitalization of over $316 billion and a P/E ratio of 35.96.

According to analysts, the stock is considered fairly valued, ranking 46 out of 155 in the Pharmaceuticals industry.

Multiple analysts have rated Merck & Co Inc as Buy, with a price target of $132.99, indicating an upside potential of over 2%.

More on Stocks

Stocks 1m ago

Amazon Seeks Approval for Massive Data Center Project in Virginia

Stocks 1m ago

Amazon's AI Spending Strategy Wins Over Skeptical Investors

Stocks 2m ago

Microsoft Cracks Down on Pirated Software with TPM-Enabled KMS Restrictions

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy